EUVIMEDEUVIMED entdecken
Open Access

High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer

Yuka Nagashima, Kazunori Sasaki, Ryosuke Chiwaki, Hayato Ishii, Kana Nohata, Yuki Maemura, Takahiro Kasai, Ayaka Ozaki, Shoma Tamori, Shigeo Ohno, Kazunori Akimoto

Cancer Genomics - Proteomics · 2025

DOI: 10.21873/cgp.20520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Yuka Nagashima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan. Hauptthemen laut MEDLINE: Protein Kinase C, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The relationship between protein kinase C zeta (PKCζ) expression and medical treatment resistance in breast cancer subtypes is unclear. Therefore, the present study aimed to analyze this relationship using disease-specific survival. MATERIALS AND METHODS: Open-source datasets with clinical and gene expression information (METABRIC, n=2509; and TCGA Pan-Cancer Atlas, n=1084) were downloaded and Kaplan-Meier survival and Cox proportional hazard analyses were performed. RESULTS: High expression of PKCζ indicated a poor prognosis in patients with luminal B type treated with endocrine therapy and aromatase inhibitor as endocrine therapy. Furthermore, catenin beta interacting protein 1 (CTNNBIP1) was identified as a differentially expressed gene between the PKCζ high and PKCζ low luminal B breast cancer cohorts treated with endocrine therapy and aromatase inhibitors. PKCζ high CTNNBIP1 high luminal B breast cancer treated with endocrine therapy and aromatase inhibitor indicated a poor prognosis. These results suggest that PKCζ and CTNNBIP1 are involved in breast cancer progression and contribute to reduced susceptibility to endocrine therapy in the luminal B breast cancer subtype. CONCLUSION: PKCζ and CTNNBIP1 may serve as a prognostic biomarker for predicting the efficacy of endocrine therapy in the luminal B breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase CBreast NeoplasmsBiomarkers, TumorHumansFemalePrognosisGene Expression Regulation, NeoplasticProtein Kinase C zeta

Stichwörter der Autor:innen

Breast cancerCTNNBIP1PKCζendocrine therapyluminal B

Substanzen

Protein Kinase CBiomarkers, TumorProtein Kinase C zeta

Autor:innen und Institutionen

  • Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
  • Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan; akimoto@rs.tus.ac.jp k.sasaki.yb@juntendo.ac.jp.
  • Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan.
  • Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan; akimoto@rs.tus.ac.jp k.sasaki.yb@juntendo.ac.jp.

Zitieren

APA

Nagashima, Y., Sasaki, K., Chiwaki, R., Ishii, H., Nohata, K., Maemura, Y., Kasai, T., Ozaki, A., Tamori, S., Ohno, S., & Akimoto, K. (2025). High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20520

Vancouver

Nagashima Y, Sasaki K, Chiwaki R, Ishii H, Nohata K, Maemura Y, et al. High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20520

BibTeX
@article{Nagashima2025,
  author = {Nagashima, Yuka and Sasaki, Kazunori and Chiwaki, Ryosuke and Ishii, Hayato and Nohata, Kana and Maemura, Yuki and Kasai, Takahiro and Ozaki, Ayaka and Tamori, Shoma and Ohno, Shigeo and Akimoto, Kazunori},
  title = {High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer},
  journal = {Cancer Genomics - Proteomics},
  year = {2025},
  doi = {10.21873/cgp.20520}
}
Kostenlos starten →